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Multiple perturbations of the immune response affecting a range of cells have
been reported in Trypanosoma cruzi-infected individuals and associated to clinical
manifestations of chronic Chagas disease. There is a paucity of knowledge about the
role of T follicular helper (Tfh) cells in this infection. Here, we sought to characterize
circulating Tfh (cTfh) cells in chronic Chagas disease patients and to identify potential
associations with disease severity in humans. cTfh cells were characterized by
flow cytometry in freshly isolated PBMCs from 7 T. cruzi-infected asymptomatic
patients (ASYMP), 5 patients with chronic chagasic dilated cardiomyopathy
(CCC) and 8 healthy controls, using antibodies against chemokine receptors
CXCR5, CXCR3, CCR6, and CCR7. Our results showed significant expansion of
CD4+CD45RO+CXCR5+CCR6+ cells in ASYMP and CCC patients, along with
a contraction of CD4+CD45RO+CXCR5+CXCR3-CCR6- (cTfh2) cells. ASYMP
patients further exhibited decreased CD4+CD45RO+CXCR5+CXCR3+CCR6- (cTfh1)
cells and expanded CD4+CD45RO+CXCR5+CXCR3-CCR6+ (cTfh17)
cells while CCC patients exhibited significantly increased frequencies of
CD4+CD45RO+CXCR5+CCR7+ cells. Linear regression analysis revealed a positive
trend of CD4+CD45RO+CXCR5+CXCR3+CCR6+ (cTfh1/17) cells and negative
trends of cTfh1 and cTfh2 cells as disease was more severe. There was no correlation
between the frequencies of cTfh cells and circulating CD19+IgD-IgG+ cells or serum
levels of T. cruzi-specific IgG. These results demonstrate that the cTfh compartment
of humans chronically infected with T. cruzi comprises expanded CCR6-expressing
cells and reduced cTfh2 cells. The association of discrete phenotypic changes in cTfh
subsets with different clinical forms suggests the potential contribution of T follicular
helper cells to Chagas heart disease progression.
Keywords: T follicular helper cells, circulating Tfh subsets, CXCR3, CCR6, Human Chagas disease,
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INTRODUCTION
Trypanosoma cruzi, the etiological agent of Chagas disease,
causes a broad spectrum of clinical outcomes, ranging
from a mild, frequently asymptomatic acute illness with low
mortality rate to a potentially life-threatening cardiomyopathy,
digestive and/or neurological abnormalities in up to 30%
of chronically infected individuals (WHO World Health
Organization, 2018). Diverse parasite and host factors have
been proposed to account for the differential clinical evolution
of Chagas disease (Bryan et al., 2010; Dutra et al., 2014).
Trypanosoma cruzi is a heterogeneous species and infection
with different strains may result in different clinical outcomes
(Quebrada Palacio et al., 2018).
Several parasite proteins have been shown to promote parasite
invasion, replication and survival (Watanabe Costa et al.,
2016). These molecules might also subvert the complement
system and favor intracellular parasite growth, thus hampering
the development of parasite-specific innate and adaptive
immune responses (Cardoso et al., 2016). Several defects
of the T cell compartment have been associated with the
progression of asymptomatic T. cruzi infection to Chagas heart
disease. Asymptomatic patients are known to develop balanced
Th1/Th2/Th17/Treg adaptive immune responses, with effector
cells producing proinflammatory cytokines such as IFN-γ, TNF-
α and IL-17, and regulatory cells producing IL-10, while patients
with the cardiac form of chronic Chagas disease exhibit a
predominantly proinflammatory cytokine profile with limited
production of IL-10 (Gomes et al., 2003; Vitelli-Avelar et al.,
2008; Dutra et al., 2014). Various B cell defects have also been
reported in T. cruzi -infected individuals, including polyclonal
B cell activation, hypergammaglobulinemia and secretion of
non-specific antibodies and autoantibodies, which have been
suggested to delay parasite-specific humoral responses, thus
contributing to parasite persistence and pathology (Minoprio
et al., 1988; Bryan et al., 2010; Bermejo et al., 2011; Cunha-Neto
et al., 2011).
CD4+ T follicular helper (Tfh) cells are a distinct
subpopulation of cytokine-producing CD4+ T helper cells
that express the chemokine receptor CXCR5 and provide
support to cognate B cell responses in germinal centers of
secondary lymphoid organs (Breitfeld et al., 2000; Schaerli et al.,
2000; Nurieva et al., 2008). A population of CD4+CXCR5+
cells has also been described in the peripheral blood (cTfh)
and proposed to represent the circulating counterpart of
bona fide Tfh cells. As for Th1, Th2 and Th17 cells (Acosta-
Rodriguez E et al., 2007), the chemokine receptors CXCR3
and CCR6 have been used to define functionally distinct
cTfh cell subsets (Morita et al., 2011; Schmitt et al., 2014).
In humans, CD4+CD45RO+CXCR5+CXCR3+CCR6-
(cTfh1) cells are known to secrete mostly IFN-
γ, while CD4+CD45RO+CXCR5+CXCR3-CCR6-
(cTfh2) cells secrete IL-4, IL-5, IL-13 and IL-21, and
CD4+CD45RO+CXCR5+CXCR3-CCR6+ (cTfh17) cells
secrete mainly IL-17, IL-21, and IL-22. Dysregulation of the
cTfh cell compartment has been reported in autoimmune
diseases, cancer and infections associated with abnormal B cell
responses (Boswell et al., 2014; Ueno et al., 2015). However,
whether Tfh cells contribute to the generation of the abnormal B
cell responses observed during T. cruzi infection remains to be
elucidated (Minoprio et al., 1988; Fernández et al., 2014). The aim
of this work was to provide an insight in the adaptive immune
response elicited by T. cruzi in humans. To this end, various
peripheral blood CD4+CD45RO+CXCR5+ cell subsets were
assessed in adult patients with different clinical forms of chronic
Chagas disease. The results showed expansion of CCR6+ cTfh
cells and decreased cTfh2 cells in infected patients, regardless
of the clinical status of the disease. Other phenotypic changes
observed include expansion of cTfh17 cells and decreased cTfh1
cells in asymptomatic patients -but not in patients with chagasic
dilated cardiomyopathy-, which suggest that dysregulation of
Tfh cells might contribute to Chagas disease progression.
MATERIALS AND METHODS
Study Population
A total of 31 adult participants were enrolled at the Clinical
Facilities of Instituto Nacional de Parasitología “Dr. Mario
Fatala Chabén,” Buenos Aires. The clinical status of enrolled
individuals was determined by physical examination and
clinical tests, including serologic testing for T. cruzi infection,
electrocardiography, chest radiography, and echocardiography.
Individuals who had positive serology for T. cruzi were grouped
according to the classification of Kuschnir et al. (1985) into:
(a) patients with no clinical manifestations of heart disease, a
normal electrocardiogram and conserved cardiac silhouette in
chest X-rays and echocardiogram (ASYMP; Kuschnir group 0; n
= 12; mean age ± SD = 48.83 ± 12.37 years) and (b) patients
with chronic Chagas dilated cardiomyopathy (CCC; Kuschnir
group 2; n = 5; mean age ± SD = 48.4 ± 7.50); clinically
healthy individuals with a negative test for T. cruzi infection
(CTRL, n = 14; mean age ± SD = 41.71 ± 13.36) served as
non-infected controls. Age of controls was matched as much as
made possible to that of the infected individuals for each assay. A
signed informed consent was obtained from all participants. All
the research was conducted in accordance with the Declaration
of Helsinki and the Council for International Organizations of
Medical Sciences (CIOMS). The study protocol was approved
by the Review Board of Instituto Nacional de Parasitología “Dr.
Mario Fatala Chabén,” Administración Nacional de Laboratorios
e Institutos de Salud Dr. Carlos G. Malbrán (IRB00006651).
Isolation of PBMC and Flow Cytometry
Assays
Freshly isolated peripheral blood mononuclear cells (PBMCs)
were separated by density gradient centrifugation on Ficoll-
Paque Plus (GE Healthcare, Uppsala, Sweden) and stained
with mAbs against CD4-FITC (Biolegend), CD45RO-PerCp-
Cy5.5 (Biolegend), CXCR5-APC (eBioscience), CCR7-PE-Cy7
(BD Pharmingen), PD1-Pac Blue (Biolegend), CXCR3-PE-
Cy7 (Biolegend), CCR6-PE (Biolegend), CD19-PE-Cy7 (BD
Pharmingen), IgD-PE (BD Pharmingen), and IgG-APC (BD
Pharmingen), following the instructions of manufacturers. Cell
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viability was monitored in all samples by incorporating Fixable
Viability Dye e-Fluor 780 (Invitrogen, Carlsbad, CA, USA) to
the stains. At least 200,000 events per sample were collected at
a FACSAria II flow cytometer (BD Immunocytometry Systems)
and analyzed using FlowJo software (Tree Star, Inc., Ashland,
OR, USA). Lymphocytes were identified by forward and side-
angle light scatter characteristics. Non-specific fluorescence
was defined with Fluorescence minus one (FMO) controls
(Hulspas et al., 2009) (Supplementary Figure 1).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
(GraphPad Software, Inc., La Jolla, CA, USA). The Kolmogorov-
Smirnov normality distribution test was applied to all data.
ANOVA followed by Bonferroni or Kruskal Wallis followed
by Dunns were used for multiple comparisons. Comparisons
between groups were made using unpaired Student’s t-test or
Mann–Whitney test. Pearson or Spearman tests were used to
determine correlation between study parameters. A simple linear
regression test was used for trend analysis. Values of p< 0.05 were
considered statistically significant.
RESULTS
Identification of Circulating T Follicular
Helper Cells in Trypanosoma cruzi-Infected
Patients
It has been well established that CXCR5 expression is essential
for migration of CD4+ T cells to B cell follicles, where they
interact with cognate B cells and provide help for the generation
of protective antibody responses (Breitfeld et al., 2000; Schaerli
et al., 2000). We therefore asked whether chronic T. cruzi
infection impacts on the circulating CD4+ cell population
with homing capability to B cell follicles. To this end, we
measured the expression of CXCR5 as frequency of overall
circulating CD4+ cells in patients with different clinical forms
of chronic Chagas disease and in healthy control subjects
(Figure 1A). No statistically significant differences were found
in the frequency of CXCR5+CD4+ cells among the study
groups (Figure 1B). Since the CXCR5 marker has been shown
to be expressed by recently activated naïve CD4+ cells and a
subset of long-lived memory CD4+ cells (Schaerli et al., 2001;
Nurieva et al., 2008; Schmitt et al., 2014), we next measured the
expression of CD45RO onCXCR5+CD4+ cells. Most circulating
CXCR5+CD4+ cells co-expressed the memory cell marker in
our study population (Figure 1C), as described by other authors
(Breitfeld et al., 2000; Schaerli et al., 2000; Schmitt et al.,
2014). Further analysis of CD45RO expression on the overall
circulating CD4+ cell population showed a significantly higher
frequency of CD4+CD45RO+ cells in T. cruzi-infected subjects,
as compared to control subjects, irrespective of the clinical
status of Chagas heart disease (P = 0.0041; Figure 1D). Thus,
cTfh cells were defined by the co-expression of CXCR5 and
CD45RO within the CD4+ cell compartment (Figure 2A). The
frequencies of CD4+CD45RO+CXCR5+ cells were not different
among the study groups. However, the CXCR5 gMFI in ASYMP
patients was significantly lower as compared to control subjects
(P = 0.0438; Figure 2B).
To determine whether T. cruzi infection leads to a change in
the phenotype of cTfh cells, we next examined the expression
of CCR7 (the chemokine receptor that controls homing to
secondary lymphoid organs) and PD-1 (a molecule highly
expressed by activated T cells) (Sallusto et al., 1999; Keir et al.,
2008). CCC patients exhibited a statistically significant higher
frequency of circulating CD4+CD45RO+CXCR5+CCR7+
cells, as compared to ASYMP patients (P = 0.0048; Figure 2C).
On the other hand, most circulating CD4+CD45RO+CXCR5+
cells did not express PD-1, indicating that cTfh cells were
in a resting status, irrespective of the infection and clinical
condition (Figure 2D). Afterward, we evaluated the expression
of chemokine receptors CXCR3 and CCR6 (classically linked
to the production of IFN-γ and IL-17, respectively; Singh et al.,
2008; Groom and Luster, 2011) on CD4+CD45RO+CXCR5+
cells. No statistically significant differences were found in the
frequency of CD4+CD45RO+CXCR5+CXCR3+ cells and
CXCR3 gMFI levels among the study groups (Figure 2E).
However, the frequencies of CD4+CD45RO+CXCR5+CCR6+
cells were significantly higher in both patient groups, as
compared to controls (P = 0.0008; Figure 2F). Besides,
CCR6 gMFI on CD4+CD45RO+CXCR5+CCR6+ cells
in ASYMP patients was significantly higher than that in
control subjects (P = 0.0121). Noteworthy, the proportions
of CD4+CD45RO+CXCR5+CCR6+ cells in ASYMP
and CCC patients were significantly higher than those of
CD4+CD45RO+CXCR5+CXCR3+ cells (P = 0.0001 and P =
0.0033, respectively; Student’s t-test), as opposed to the balanced
distribution of these cells observed in healthy controls (P =
0.6550; Student’s t-test). Altogether, these data suggest that the
infection with T. cruzi induces a shift of the cTfh compartment
toward a Th17-like phenotype.
Chronic Chagas Disease Is Associated
With a Defective cTfh Cell Subset
Composition
The differential co-expression of CXCR3 and CCR6 was then
used to define functionally distinct cTfh subsets (Figure 3A).
ASYMP patients showed decreased cTfh1 cell frequencies, as
compared to controls (P = 0.0282; Figure 3B); nevertheless,
linear regression analysis revealed a negative trend in the
frequency of these cells as the disease severity increased (P =
0.0271, slope = −3.747). No differences in CXCR3 gMFI levels
were observed among the study groups. The frequency of cTfh2
cells in ASYMP and CCC patients was significantly lower, as
compared to controls (P = 0.0043; Figure 3C), with a negative
trend in these cells as the infection was more severe (P =
0.0026, slope= −3.747). Conversely, the frequency of cTfh17
cells was significantly increased in ASYMP patients, as compared
to controls (P = 0.0359; Figure 3D). Additionally, CCR6 gMFI
levels on these cells were significantly higher in ASYMP patients,
as compared to both CCC patients and controls (P = 0.0178).
The frequency of cTfh1/17 (Liu et al., 2017) cells was similar
among the study groups (Figure 3E), though a positive trend was
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 March 2020 | Volume 10 | Article 126
Quebrada Palacio et al. cTfh Cells in Chagas Disease
FIGURE 1 | CXCR5 and CD45RO expression in peripheral blood CD4+ cells of chronic Chagas disease patients. Freshly isolated PBMCs were stained with
fluorochrome-conjugated Abs against CD4, CXCR5 and CD45RO markers. (A) Gating strategy used for the identification of circulating CXCR5+ and CD45RO+ cells
in CD4+ T cells. Data are presented as frequencies of CXCR5+ cells in CD4+ cells (B), CD45RO+ cells in CXCR5+CD4+ cells (C) and CD45RO+ cells in CD4+
cells (D). Each symbol represents an individual; mean values ±SD are represented by horizontal lines.*p < 0.05; ANOVA followed by Bonferroni.
observed with disease progression (P = 0.0327, slope 3.921). In
these cells, CXCR3 gMFI levels were similar among the study
groups; however, CCR6 gMFI levels were significantly higher
in ASYMP -but not in CCC- patients, as compared to controls
(P = 0.0182; Figure 3E).
Previous studies from our lab have shown a progressive
decrease in T. cruzi-specific CD4+ IFN-γ+ cell numbers
as Chagas heart disease was more severe (Albareda et al.,
2009). Other authors have reported that the Th1 effector
cytokine IFN-γ inhibits the development of Th17 effector
responses (Harrington et al., 2005). T-bet, the transcription
factor involved in the differentiation of Th1 cells has
been demonstrated to inhibit T. cruzi-specific CD4+
Th17 cell responses in vivo (Guo et al., 2009). We here
analyzed the relationship between different cTfh subsets
by linear regression and found that the frequency of
cTfh1 cells inversely correlated with that of cTfh17 cells
in infected patients as well as in controls (Figure 4). No
correlation between cTfh1 vs. cTfh2, and cTfh2 vs. cTfh17
cell frequencies was found. Similarly, the frequency of
CD4+CD45RO+CXCR5+ cells did not correlate with
the frequency of circulating CD19+IgD-IgG+ B cells
(Supplementary Table 1). We also failed to detect a relationship
between the frequencies of cTfh subsets and serum levels
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FIGURE 2 | Phenotypic analysis of circulating memory T follicular helper cells in Chagas disease patients. (A) Gating strategy. CXCR5 and CD45RO double-positive
CD4+ T cells were analyzed for the expression of CCR7, CXCR3, CCR6, and PD1 markers by flow cytometry. (B) Percentages of CD4+CD45RO+CXCR5+ cells and
CXCR5 gMFI. (C) Percentages of CD4+CD45RO+CXCR5+CCR7+ cells. (D) Percentages of CD4+CD45RO+CXCR5+PD1+,
(E) CD4+CD45RO+CXCR5+CXCR3+ and CXCR3 gMFI. (F) CD4+CD45RO+CXCR5+CCR6+ and CCR6 gMFI. Each symbol represents an individual; mean values
±SD are represented by horizontal lines. Bars represent the geometric mean fluorescence intensity of chemokine receptors CXCR5, CXCR3, and CCR6; error bars
represent SD. *p < 0.05 and **p < 0.01; Kluskal–Wallis followed by Dunn’s or ANOVA followed by Bonferroni.
of T. cruzi-specific IgG antibodies, as measured by ELISA
(data not shown).
As IFN-γ and IL-17 were proposed to play critical roles
in the pathogenesis of Chagas disease cardiomyopathy
(Magalhães et al., 2013; Dutra et al., 2014), we extended
our phenotypic analysis of CXCR3 and CCR6 expression
to CD4+, CD4+CD45RO+ and CD4+CD45RO+CXCR5-
(non-follicular memory) cells. No differences were observed
in the frequencies of CD4+ cells and CD4+CD45RO+
cells expressing either marker among the study groups
(Supplementary Table 1). The proportion of CXCR3+
cells within the CD4+CD45RO+CXCR5- compartment
was significantly higher than that of CCR6+ cells in healthy
controls (P = 0.0012; Student t-test), but not in infected
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FIGURE 3 | Altered distribution of circulating T follicular helper subsets during chronic T. cruzi infection. (A) Gating strategy. cTfh memory cells were analyzed for the
differential co-expression of CXCR3 and CCR6 by flow cytometry. Frequencies of cTfh1 (B), cTfh2 (C), cTfh17 (D) and cTfh1/17 cells (E). Each symbol represents an
individual; mean values ±SD are represented by horizontal lines. Bars represent the CCR6 gMFI; error bars represent SD. *p < 0.05; ANOVA followed by Bonferroni.
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FIGURE 4 | Correlation analysis between cTfh subset frequencies. cTfh17 cell frequencies inversely correlate with cTfh1 cell frequencies in Chagas disease patients
and healthy subjects. There is no correlation of cTfh17 vs. cTfh2 cell frequencies, and cTfh1 vs. cTfh2 cell frequencies. p < 0.05 was consider significant; Pearson
correlation coefficient test.
patients (p > 0.05). These data suggest that Th1 polarization
of non-follicular memory CD4+ cells does not occur in
chronic Chagas disease patients. We next measured CXCR3
and CCR6 co-expression in CD4+CD45RO+CXCR5- cells and
found similar frequencies of CXCR3+CCR6-, CXCR3-CCR6-,
CXCR3-CCR6+ and CXCR3+CCR6+ cells among the study
groups (Supplementary Table 1).
DISCUSSION
The relevance of abnormal T and B cell responses in the
progression of chronic Chagas disease has received considerable
attention. Multiple T cell subsets and cytokines seem to be
involved in the pathogenesis of Chagas cardiomyopathy, but
the exact mechanisms leading to parasite persistence and
tissue damage have not been fully established. Classically,
effector T helper cells include distinct subsets which can be
distinguished by specific activating transcription factors, the
profile of cytokines they secrete upon re-stimulation and the
chemokines defining their migration properties (Deenick et al.,
2011). T follicular helper cells represent a particular lineage of
CD4+ helper cells that provide essential support to cognate
B cells for proliferation, somatic hypermutation, class-switch
recombination, and selection of high affinity B cells in germinal
centers of secondary lymphoid organs (Crotty, 2015). In this
study, we evaluated the expression of the chemokine receptors
CXCR3 and CCR6 on CD4+CD45RO+CXCR5+ cells from
patients chronically infected with T. cruzi. The results of our
approach exposed a dysbalanced cTfh cell composition, which
includes a progressive contraction of cTfh1 and cTfh2 cells,
expansion of cTfh1/17 cells and increased frequency of CCR6+
cells as disease was more severe. Further analysis of cTfh17
and cTfh1/17 exposed the association of increased CCR6 cell
expression with asymptomatic disease, supporting the concept
that IL-17 plays a protective role against the progression to
Chagas cardiomyopathy proposed by other authors (Magalhães
et al., 2013). The contraction of cTfh1 cells was more marked in
asymptomatic patients, and it was accompanied by the expansion
of cTfh17 cells. It is plausible that the shift toward a Th17-like
phenotype observed occurs during early stages of CD4+ T cell
differentiation, since IFN-γ and IL-4 are known to antagonize
naive, but not mature Th17 cells (Harrington et al., 2005). The
exact mechanisms involved in the generation of expanded cTfh17
cells and contracted cTfh1 and cTfh2 cells during chronic T. cruzi
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infection remains to be determined. This is the first report of
the impact of chronic T. cruzi infection on the population of
circulating Tfh cells. Although yet to be established, the altered
composition of cTfh cells may reflect changes in germinal center
dynamics that could play a role in the pathogenesis of Chagas
disease. A better understanding of the functionality of these cells
will likely provide new and important clues about the immune
response against T. cruzi and the potential implication of cTfh
cells in the progression to Chagas disease cardiomyopathy.
The differentiation of activated B cells into immunoglobulin-
secreting cells in tonsils was demonstrated to be largely mediated
by Tfh cell-derived IL-21 (Bryant et al., 2007). Different authors
have demonstrated that peripheral blood Tfh17 and Tfh2 cells
produce IL-21 more efficiently than other circulating Tfh and
Th subpopulations, and are thus considered efficient B helper
cells (Morita et al., 2011; Schmitt et al., 2014). In contrast with
reports on humoral responses in autoimmune diseases (Morita
et al., 2011), in this work we failed to demonstrate any association
of cTfh subsets with the frequency of IgG+ mature B cells
ex-vivo and the levels of serum T. cruzi-specific antibodies.
This phenomenon could be attributed to humoral T. cruzi-
specific responses being regulated by mechanisms other than Tfh
cells, including T cell-independent pathways, as proposed for
humanHIV infection (Boswell et al., 2014). Interestingly, massive
extrafollicular B cell responses were described as an important
source of non-specific antibodies in mice acutely infected with
T. cruzi (Bermejo et al., 2011). Otherwise, peripheral blood Tfh
cells in chronic T. cruzi infection might not fully represent the
pool of Tfh cells residing in germinal centers.
Naïve CD4+ T cells are known to constitutively express
CCR7, a key molecule for cell migration toward CCL19 and
CCL21 ligands expressed in the T-zones of secondary lymphoid
organs. Diverse cytokines and inflammatory mediators have been
shown to modulate the expression of CCR7 and immune cell
activation (Comerford et al., 2013). The attenuation of CCR7
expression and the induction of CXCR5 facilitate the entry
of CD4+ cells into B cell follicles and GC in response to
CXCL13 expression; CCR7 recycles back to the cell membrane
after egressing from lymph nodes in a sphingosine-1-phosphate
receptor-1 (S1P1)- dependent manner (Matloubian et al., 2004).
Conversely, the maintenance of CCR7 expression was shown to
inhibit the access of CXCR5+ cells to follicles (Haynes et al.,
2007). Chronic chagasic cardiomyopathy is characterized by
myocardial cell necrosis, fibrosis and active inflammatory process
involving CD8+ and CD4+ T cells, NK cells and macrophages
which secrete mainly proinflamatory cytokines (Dutra et al.,
2014). It is possible that inflammatory mediators associated with
cardiac lesions induce the expression of CCR7 on CXCR5+ cells,
promoting the re-circulation of CCR7+ cTfh cells and their
accumulation in the peripheral blood.
An additional finding of our study was the expansion of
peripheral blood CD4+CD45RO+ cells associated with chronic
T. cruzi infection, which contrasts with the unaltered proportion
of CD4+CD45RO+ cells ex-vivo reported by Fiuza et al. (2009).
It is possible that this discrepancy be due to the influence of
parasite and host genetic diversity on the outcome of human
Chagas disease, as suggested by other authors (Santos D et al.,
2009; Zingales et al., 2012; Poveda et al., 2014).
In summary, in this work we characterized circulating
Tfh cells in patients chronically infected with T. cruzi and
demonstrated an imbalance in the distribution of cTfh subsets
associated with the clinical forms of Chagas disease. The major
weakness of the present study is the relatively low number
of patients with dilated chagasic cardiomyopathy included in
the analysis. Moreover, we were unable to obtain data on the
cytokine profile and functionality of cTfh cells that could lead
to a better understanding of their role in the pathogenesis of
chronic Chagas heart disease. However, our detailed phenotypic
characterization provides indirect evidence of a potential role
of Tfh cells in the abnormal immune responses against T. cruzi
(Fernández et al., 2014), establishing the basis to perform further
studies to assess these processes.
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